History
  • No items yet
midpage
Smartgene, Inc. v. Advanced Biological Laboratories, Sa
852 F. Supp. 2d 42
D.D.C.
2012
Read the full case

Background

  • SmartGene, Inc. sought declaratory judgment of invalidity, non-infringement, and unenforceability of U.S. Patent Nos. 6,081,786 and 6,188,988.
  • Patents pertain to systems, methods, and computer programs for guiding therapeutic treatment regimens for patients with known diseases, using data inputs, knowledge bases, and ranked regimens with advisory information.
  • The patents share the same specifications and teach an interactive, computerized program assisting physicians in selecting treatments.
  • A stay occurred while PTO reexaminations were conducted; the PTO ultimately found all claims patentable over prior art, without addressing § 101 subject matter eligibility.
  • SmartGene moved for partial summary judgment contending § 101 ineligibility; the court held § 101 threshold analysis disfavors the patents.
  • The court concluded the claims are ineligible subject matter and dismissed the case, with all remaining claims and counterclaims moot.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Are the patents eligible under 35 U.S.C. §101? SmartGene contends the claims claim abstract ideas and mental processes not patentable. ABL argues the claims describe an interactive system and computer program aiding physicians, satisfying eligibility. Patents are not patentable under §101; invalid.
Do the claims satisfy the machine-or-transformation (MOT) test? SmartGene asserts no meaningful machine or transformation limits, merely mental steps. ABL argues the invention ties to a computing device and databases, fulfilling MOT. Claims fail both MOT prongs; not patentable.
Do § 101 considerations override PTO reexamination deference? Not explicit in the record; reexamination does not address §101, so §101 must be evaluated anew. PTO proceedings are not dispositive of §101; patent eligibility remains a separate threshold issue. §101 threshold analysis governs; PTO findings do not trump §101.

Key Cases Cited

  • Diamond v. Diehr, 450 U.S. 175 (1981) (integration of a formula with other steps can render a process patentable)
  • Gottschalk v. Benson, 409 U.S. 63 (1972) (mathematical algorithms preempting basic tools are not patentable)
  • Parker v. Flook, 437 U.S. 584 (1978) (post-solution activity cannot make unpatentable abstract ideas patentable)
  • Bilski v. Kappos, 561 U.S. 593 (2010) (MOT test is a useful guidance but not the only test for §101)
  • Prometheus Labs., Inc. v. Mayo Collaborative Servs., 132 S. Ct. 1289 (2012) (natural law claims unpatentable unless the claim adds significant further inventive steps)
  • In re Meyer, 688 F.2d 789 (1982) (claims reciting a mathematical algorithm may be unpatentable when they mirror mental steps)
  • CyberSource Corp. v. Retail Decisions, Inc., 654 F.3d 1366 (2011) (data manipulation claims can be non-patentable abstract ideas when performed in the mind)
Read the full case

Case Details

Case Name: Smartgene, Inc. v. Advanced Biological Laboratories, Sa
Court Name: District Court, District of Columbia
Date Published: Mar 30, 2012
Citation: 852 F. Supp. 2d 42
Docket Number: Civil Action No. 2008-0642
Court Abbreviation: D.D.C.